PortfoliosLab logoPortfoliosLab logo
FUSN vs. MPTI
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

FUSN vs. MPTI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fusion Pharmaceuticals Inc. (FUSN) and M-tron Industries Inc (MPTI). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

FUSN vs. MPTI - Yearly Performance Comparison


2026 (YTD)2025202420232022
FUSN
Fusion Pharmaceuticals Inc.
0.00%0.00%124.25%205.08%2.94%
MPTI
M-tron Industries Inc
25.61%31.87%35.66%308.00%-33.21%

Fundamentals

Total Revenue (TTM)

FUSN:

$35.68M

MPTI:

$54.42M

Gross Profit (TTM)

FUSN:

$32.98M

MPTI:

$24.15M

EBITDA (TTM)

FUSN:

-$99.14M

MPTI:

$11.59M

Returns By Period


FUSN

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*

MPTI

1D
1.00%
1M
5.62%
YTD
25.61%
6M
20.49%
1Y
50.09%
3Y*
95.42%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FUSN vs. MPTI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FUSN

MPTI
MPTI Risk / Return Rank: 6969
Overall Rank
MPTI Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
MPTI Sortino Ratio Rank: 6868
Sortino Ratio Rank
MPTI Omega Ratio Rank: 6767
Omega Ratio Rank
MPTI Calmar Ratio Rank: 7272
Calmar Ratio Rank
MPTI Martin Ratio Rank: 6969
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FUSN vs. MPTI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fusion Pharmaceuticals Inc. (FUSN) and M-tron Industries Inc (MPTI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

FUSN vs. MPTI - Sharpe Ratio Comparison


Loading graphics...

Sharpe Ratios by Period


FUSNMPTIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.83

Sharpe Ratio (All Time)

Calculated using the full available price history

0.96

Correlation

The correlation between FUSN and MPTI is 0.02, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

FUSN vs. MPTI - Dividend Comparison

Neither FUSN nor MPTI has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

FUSN vs. MPTI - Drawdown Comparison


Loading graphics...

Drawdown Indicators


FUSNMPTIDifference

Max Drawdown

Largest peak-to-trough decline

-49.99%

Max Drawdown (1Y)

Largest decline over 1 year

-35.14%

Current Drawdown

Current decline from peak

-13.25%

Average Drawdown

Average peak-to-trough decline

-19.44%

Ulcer Index

Depth and duration of drawdowns from previous peaks

17.21%

Volatility

FUSN vs. MPTI - Volatility Comparison


Loading graphics...

Volatility by Period


FUSNMPTIDifference

Volatility (1M)

Calculated over the trailing 1-month period

26.11%

Volatility (6M)

Calculated over the trailing 6-month period

39.58%

Volatility (1Y)

Calculated over the trailing 1-year period

60.82%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

71.50%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

71.50%

Financials

FUSN vs. MPTI - Financials Comparison

This section allows you to compare key financial metrics between Fusion Pharmaceuticals Inc. and M-tron Industries Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M25.00M30.00M35.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober0
14.23M
(FUSN) Total Revenue
(MPTI) Total Revenue
Values in USD except per share items